92 related articles for article (PubMed ID: 2911044)
1. Rapid blood clearance of biotinylated IgG after infusion of avidin.
Sinitsyn VV; Mamontova AG; Checkneva YY; Shnyra AA; Domogatsky SP
J Nucl Med; 1989 Jan; 30(1):66-9. PubMed ID: 2911044
[TBL] [Abstract][Full Text] [Related]
2. [Use of avidin for speedy clearance of biotinylated immunoglobulins from the blood flow].
Sinitsyn VV; Mamontova AG; Chekneva EE; Shnyra AA; Domogatskiĭ SP
Biull Eksp Biol Med; 1990 Jun; 109(6):567-9. PubMed ID: 2397294
[TBL] [Abstract][Full Text] [Related]
3. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
[TBL] [Abstract][Full Text] [Related]
4. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
[TBL] [Abstract][Full Text] [Related]
6. Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies.
Klibanov AL; Martynov AV; Slinkin MA; Sakharov IYu ; Smirnov MD; Muzykantov VR; Danilov SM; Torchilin VP
J Nucl Med; 1988 Dec; 29(12):1951-6. PubMed ID: 2848113
[TBL] [Abstract][Full Text] [Related]
7. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
[TBL] [Abstract][Full Text] [Related]
8. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
Kang YS; Pardridge WM
J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
[TBL] [Abstract][Full Text] [Related]
9. Reusability of avidin-biotinylated immunoglobulin Y columns in immunoaffinity chromatography.
Kim HO; Durance TD; Li-Chan EC
Anal Biochem; 1999 Mar; 268(2):383-97. PubMed ID: 10075830
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
Kang YS; Boado RJ; Pardridge WM
Drug Metab Dispos; 1995 Jan; 23(1):55-9. PubMed ID: 7720525
[TBL] [Abstract][Full Text] [Related]
11. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
Arany E; Zabel P; Hill DJ
Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
[TBL] [Abstract][Full Text] [Related]
12. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.
Penichet ML; Kang YS; Pardridge WM; Morrison SL; Shin SU
J Immunol; 1999 Oct; 163(8):4421-6. PubMed ID: 10510383
[TBL] [Abstract][Full Text] [Related]
13. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
Otsuji E; Yamaguchi T; Yamamoto K; Matsumura H; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
Jpn J Cancer Res; 1997 Feb; 88(2):205-12. PubMed ID: 9119750
[TBL] [Abstract][Full Text] [Related]
14. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96.
Chen JQ; Strand SE; Tennvall J; Lindgren L; Hindorf C; Sjögren HO
J Nucl Med; 1997 Dec; 38(12):1934-9. PubMed ID: 9430473
[TBL] [Abstract][Full Text] [Related]
16. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
Veerhuis R; van Es LA; Daha MR
Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
[TBL] [Abstract][Full Text] [Related]
17. [Application of biotin-avidin system in targeted magnetic resonance imaging].
Liu X; Xu YK; Ye J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
Garkavij M; Tennvall J; Strand SE; Sjögren HO; JianQing C; Nilsson R; Isaksson M
J Nucl Med; 1997 Jun; 38(6):895-901. PubMed ID: 9189138
[TBL] [Abstract][Full Text] [Related]
19. Enhanced elimination of biotinylated antibodies by avidin-based hemoperfusion in rats.
Burkhart KK; Beard D; Billingsley ML
J Pharmacol Exp Ther; 1994 Jul; 270(1):356-61. PubMed ID: 8035331
[TBL] [Abstract][Full Text] [Related]
20. Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes.
Muzykantov VR; Seregina N; Smirnov MD
Int J Artif Organs; 1992 Oct; 15(10):622-7. PubMed ID: 1428212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
